Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis

Table 1 Clinical features of patients in HTG and control groups

	HTG group (n = 45)	Control group (n = 131)
Sex (Male/Female)	27/18	72/59
Age (mean ± SD, yr)	40.8 ± 9.3 (24-61)a	52.6 ± 13.4 (22-82)
Etiology, n (%)
Overeating and high fat diet	18 (40.0)a	19 (14.5)
Alcohol abuse	21 (46.7)b	31 (23.7)
Gallstones	5 (11.1)b	37 (28.2)
L-Asparaginase chemotherapy	2 (4.4)	0
Pregnancy	6 (13.3)	0
Underlying diseases, n (%)
Hypertension	6 (13.3)	15 (11.5)
Coronary heart disease	3 (6.7)	7 (5.3)
Atherosclerosis	3 (6.7)	9 (6.9)
Familial hyperlipidemia	6 (13.3)	11 (8.4)
Admission biochemical
Serum glucose (mmol/L)	17.7 ± 7.7b	13.4 ± 6.1
Hypoalbuminaemia (%)	38 (84.4)b	79 (60.3)
Hypocalcaemia (%)	39 (86.7)b	83 (63.4)
Hypopotassemia (%)	16 (35.6)	50 (38.2)
Hyponatremia (%)	26 (57.8)	59 (45.0)
Ranson’s score (mean ± SD)	4.7 ± 1.9	4.9 ± 2.0
24-h APACHE II score (mean ± SD)	13.6 ± 5.7b	10.7 ± 4.6
Balthazar’s CT score (mean ± SD)	5.4 ± 2.3	6.3 ± 5.4

^aP < 0.05,

^bP < 0.01 vs control group.

Table 2 Incidence of complications and mortality in HTG and control groups n (%)

	HTG group (n = 45)	Control group ( n = 131)
Complications
ARDS	29 (64.4)	61 (46.6)
Renal failure	23 (51.1)b	22 (16.8)
Acute hepatitis	20 (44.4)	38 (29.0)
Shock	17 (37.9)b	19 (14.5)
Encephalopathy	10 (22.2)	24 (18.3)
Infection	17 (37.4)b	24 (18.3)
Death	14 (31.1)b	12 (9.1)

^bP < 0.01 vs control group.